Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, Madison, Wisconsin, USA.
J Surg Res. 2012 Oct;177(2):241-7. doi: 10.1016/j.jss.2012.07.059. Epub 2012 Aug 15.
Primary aldosteronism caused by an aldosterone producing adrenal tumor/aldosteronoma (APA), is a potentially curable form of hypertension, via unilateral adrenalectomy. Resolution of hypertension (HTN) is not as prevalent after tumor resection, as are the normalization of aldosterone secretion, hypokalemia, and other metabolic abnormalities. Here, we review the immediate and long-term medical outcomes of laparoscopic adrenalectomy in patients with an APA, and attempt to identify any distinctive sex differences in the management of resistant HTN.
We performed a retrospective review of the prospective adrenal database at the University of Wisconsin between January 2001 and October 2010. Of the 165 adrenalectomies performed, 32 were for the resection of an APA. Patients were grouped according to their postoperative HTN status. Those patients with normal blood pressure (≤120/80 mm Hg) and on no antihypertensive medication (CURE) were compared with those who continued to require medication for blood pressure control (HTN). We evaluated sex, age, body mass index, tumor size, duration of time with high blood pressure, and the differences in systolic and diastolic blood pressure following adrenalectomy. Statistical analysis was performed using Student's t-test. Statistical significance was defined as a P value of <0.05.
We identified 32 patients with an APA based on biochemical and radiographic studies, two patients were excluded, due to missing data. There were 19 males (63%) and 11 (37%) females, with a mean age was 48.3 ± 2.1 y, and mean tumor size was 24 ± 3 mm. Postoperatively, patients required significantly fewer antihypertensive medications (1.5 ± 0.2 versus 3.3 ± 0.3, P < 0.001). Nine patients (31%) had complete resolution of their HTN, requiring no postoperative antihypertensive medication. The only significant difference between the sexes, was a lower body mass index in women (27.6 ± 1.7 versus 33.4 ± 2.1 kg/m(2), P = 0.04). Ninety percent of the cohort had at least a 20 mm Hg decline in their systolic blood pressure postoperatively, placing them in the prehypertensive or normal blood pressure categories. Sixty-six percent of the CURE patients required at least 6 mo for resolution of their HTN. All 20 patients who presented with hypokalemia, had immediate resolution postoperatively and did not require continuance of the preoperative spironolactone or potassium supplementation.
Laparoscopic adrenalectomy for aldosterone producing adenoma results in the normalization of, or more readily manageable blood pressure in 90% of patients, within 6 mo. Metabolic disturbances are immediately corrected with tumor resection. Weight is an important contributing factor in resolving HTN.
由醛固酮产生的肾上腺肿瘤/醛固酮瘤(APA)引起的原发性醛固酮增多症是一种潜在可治愈的高血压形式,通过单侧肾上腺切除术。肿瘤切除后,高血压(HTN)的缓解并不像醛固酮分泌、低钾血症和其他代谢异常的正常化那样常见。在这里,我们回顾了腹腔镜肾上腺切除术治疗 APA 患者的即刻和长期医疗结果,并试图确定在治疗耐药性 HTN 方面是否存在任何明显的性别差异。
我们对 2001 年 1 月至 2010 年 10 月期间威斯康星大学前瞻性肾上腺数据库进行了回顾性分析。在进行的 165 次肾上腺切除术,32 次为切除 APA。根据术后高血压状态对患者进行分组。那些血压正常(≤120/80mmHg)且无需服用降压药物(CURE)的患者与那些继续需要降压药物控制血压的患者进行比较(HTN)。我们评估了性别、年龄、体重指数、肿瘤大小、高血压持续时间以及肾上腺切除术后收缩压和舒张压的差异。使用 Student's t 检验进行统计学分析。统计学意义定义为 P 值<0.05。
我们根据生化和影像学研究确定了 32 名 APA 患者,由于数据缺失,排除了 2 名患者。有 19 名男性(63%)和 11 名女性(37%),平均年龄为 48.3±2.1 岁,平均肿瘤大小为 24±3mm。术后,患者需要的降压药物明显减少(1.5±0.2 与 3.3±0.3,P<0.001)。9 名患者(31%)的高血压完全缓解,无需术后降压药物。性别之间唯一的显著差异是女性的体重指数较低(27.6±1.7 与 33.4±2.1kg/m2,P=0.04)。90%的患者术后收缩压至少下降 20mmHg,处于高血压前期或正常血压范围。66%的 CURE 患者需要至少 6 个月才能缓解高血压。所有 20 名出现低钾血症的患者术后立即得到缓解,且无需继续服用术前螺内酯或补钾。
腹腔镜肾上腺切除术治疗醛固酮腺瘤可使 90%的患者在 6 个月内恢复正常或更容易控制血压,高血压可在 6 个月内得到缓解。代谢紊乱随着肿瘤切除而立即得到纠正。体重是高血压缓解的一个重要因素。